Ultrasound test to tell GIST from leiomyoma
Part of Cancer, Digestive system clinical trials.
This study tests a special contrast-enhanced ultrasound to help doctors tell the difference between two types of growths in the gut: GISTs and leiomyomas. If you have one of these growths and are scheduled for an endoscopic ultrasound, this test might provide clearer information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a growth in your digestive tract that your doctor plans to examine with an ultrasound.
- You have had the growth diagnosed as either a GIST or a leiomyoma through a biopsy or surgery.
- You are not pregnant, and you do not have severe heart or lung problems.
- You do not have a known allergy to the ultrasound contrast dye.
- You are willing and able to give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help diagnose tumors in the upper stomach or esophagus. It looks at images from endoscopy and ultrasound to improve how doctors identify these growths.
This study looks at how surgery for gastrointestinal stromal tumors (GIST) works, and collects tumor samples to study them under the microscope and by DNA testing. Your results may help researchers better predict tumor behavior and guide future treatment.
This trial tests a new surgical approach combining laparoscopic (minimally invasive) surgery with endoscopy (a camera procedure) to remove small tumors located where the esophagus meets the stomach. The goal is to safely remove these tumors while preserving normal function.
This trial studies advanced GIST cancers that have stopped responding to all four standard treatments. It uses PET-CT scans and genetic testing of tumor tissue to understand resistance, helping to find the best next treatment.
This study uses a special type of MRI to see how well imatinib, a targeted cancer pill, is working in people with GIST. It may help doctors understand which patients are responding best to treatment.
This trial compares two special camera methods (pCLE and EB) used during endoscopy to better see and diagnose early stomach changes. It may help doctors decide the best treatment for precancerous spots or very early cancer.
Hear when a new Gastrointestinal Stromal Tumor (GIST) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.